Sputnik V has been developed by the Gamaleya Research Institute of
Epidemiology and Microbiology along with Russian Direct Investment
Fund (RDIF). The vaccine has not been tested in phase 3 or larger
clinical trials. There has been scepticism in some quarters about
limited data related to the efficacy of the vaccine.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/russia-seeks-collaboration-with-india-for-manufacturing-covid-19-vaccine-sputnik-v-sources/articleshow/77744451.cms
No comments:
Post a Comment